PubRank

Murray Esler

Author PubWeight™ 67.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009 10.53
2 Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 2013 3.44
3 Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011 2.88
4 Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2009 2.04
5 Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010 2.01
6 Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension 2007 1.90
7 The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007 1.80
8 The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J 2012 1.74
9 Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol 2012 1.66
10 Interactions between leptin and the human sympathetic nervous system. Hypertension 2003 1.44
11 New drugs, procedures, and devices for hypertension. Lancet 2012 1.32
12 Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics 2003 1.32
13 Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A 2005 1.24
14 Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol 2011 1.22
15 Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 2011 1.18
16 Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med 2002 1.15
17 Increased suicide rate in the middle-aged and its association with hours of sunlight. Am J Psychiatry 2003 1.14
18 Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens 2007 1.12
19 Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol 2011 1.12
20 Blood pressure and sympathetic nervous system response to renal denervation. Hypertension 2012 1.08
21 Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol 2008 1.02
22 Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol (1985) 2006 1.01
23 Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens 2012 1.00
24 Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 2005 0.97
25 Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One 2013 0.96
26 Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc Res 2005 0.94
27 Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010 0.94
28 The neurobiology of human obesity. Exp Physiol 2005 0.94
29 Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011 0.93
30 Epigenetic modification of the norepinephrine transporter gene in postural tachycardia syndrome. Arterioscler Thromb Vasc Biol 2012 0.92
31 Heart and mind: psychogenic cardiovascular disease. J Hypertens 2009 0.88
32 European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens 2010 0.86
33 Single-unit analysis of sympathetic nervous discharges in patients with panic disorder. J Physiol 2005 0.86
34 Single-unit sympathetic discharge pattern in pathological conditions associated with elevated cardiovascular risk. Clin Exp Pharmacol Physiol 2008 0.85
35 Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens 2012 0.83
36 Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? Hypertension 2010 0.82
37 Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 2004 0.82
38 Sympathetic nervous system neuroplasticity. Hypertension 2006 0.81
39 Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension 2013 0.81
40 Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. Hypertension 2010 0.81
41 Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol 2010 0.80
42 The sympathetic nervous system in renovascular hypertension: lead actor or 'bit' player? J Hypertens 2002 0.80
43 Influence of leptin on neurotransmitter overflow from the rat brain in vitro. Regul Pept 2002 0.79
44 Is very high sympathetic tone in heart failure a result of keeping bad company? Hypertension 2003 0.79
45 Transcatheter aortic valve implantation reduces sympathetic activity and normalizes arterial spontaneous baroreflex in patients with aortic stenosis. JACC Cardiovasc Interv 2013 0.78
46 NPY and NPY Y1 receptor effects on noradrenaline overflow from the rat brain in vitro. Regul Pept 2004 0.77
47 An explanation of the unexpected efficacy of L-DOPS in pure autonomic failure. Clin Auton Res 2004 0.77
48 Is essential hypertension sometimes a psychosomatic disorder? J Hypertens 2004 0.76
49 On a low calorie diet, are there separate and discrete effects of negative energy balance and weight loss on blood pressure? J Hypertens 2003 0.75
50 Cardiovascular trophic effects from the sympathetic nerve cotransmitter neuropeptide Y in end-stage renal disease? J Hypertens 2003 0.75
51 Development of the metabolic syndrome along the female biological life-path. J Hypertens 2006 0.75
52 Reduced HRV and baroreflex sensitivity as universally applicable cardiovascular "risk factors"; waiting for the bubble to burst. Clin Auton Res 2003 0.75
53 Response to more research is needed to investigate the effect of denervation on blood pressure. Hypertension 2014 0.75
54 Depressive illness, the sympathetic nervous system and cardiac risk. J Hypertens 2009 0.75
55 ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. J Hypertens 2016 0.75
56 OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. J Hypertens 2016 0.75
57 OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. J Hypertens 2016 0.75
58 OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION. J Hypertens 2016 0.75
59 ISH NIA OS-01 THE microRNA miR-19a-3p BINDS TO A POLYMORPHISM IN THE GENE FOR THE NORADRENALINE TRANSPORTER AND MAY INCREASE THE RISK OF CARDIOVASCULAR AND PSYCHIATRIC DISEASE. J Hypertens 2016 0.75
60 OS 19-01 BLOOD PRESSURE INDEPENDENT EFFECTS OF RENAL DENERVATION ON THE DECLINE OF KIDNEY FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE. J Hypertens 2016 0.75
61 Is "cardiovascular protection" by estrogens due to inhibition of the sympathetic nervous system? Clin Auton Res 2005 0.75